Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Canada

BMO Equal Weight US Health Care Hedged to CAD Index ETF

+ Add to Watchlist

ZUH:CN

25.5500 CAD 0.1600 0.63%

As of 15:59:56 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)

Open: 25.3800 High - Low: 25.5700 - 25.3800 Primary Exchange: Toronto
Volume: 13,910 52-Week Range: 18.1600 - 25.7300 Beta vs DJLHECHT: 0.9102

ETF Chart for ZUH

No chart data available.
  • ZUH:CN 25.5500
  • 1D
  • 1M
  • 1Y
25.3900
Interactive ZUH Chart

Previous Close

Fund Profile & Information for ZUH

BMO Equal Weight US Health Care Hedged to CAD Index ETF is an exchange-traded fund incorporated in Canada. The ETF has been designed to replicate, to the extent possible, the Dow Jones U.S. Large-Cap Health Care Equal Weight Total Stock Market Index Canadian Dollar Hedged. The Fund seek to invest in and hold the Constituent Securities of the Index.

Inception Date: 2010-05-25 Telephone: 1-416-359-5000
Managers: -
Web Site: www.bmoetfs.com

Fundamentals for ZUH

NAV (on 2013-05-17) 25.5753
Assets (M) (on 2013-03-28) 23.5264
Shares out (M) 1.10
Market Cap (M) 28.10
% Premium -0.10
Average 52-Week % Premium 0.0205
Fund Leveraged N

Dividends for ZUH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2012-12-24) 0.1190
Dividend Yield (ttm) 0.47%

Performance for ZUH

1-Month +6.15% 1-Year +37.49%
3-Month +13.81% 3-Year -
Year To Date +25.06% 5-Year -
Expense Ratio 0.40

Top Fund Holdings for ZUH

Filing Date: 05/15/2013
Name Position Value % of Total
Regeneron Pharmaceuticals Inc 3,155 879,735 3.087%
Vertex Pharmaceuticals Inc 10,380 838,600 2.943%
Actavis Inc 6,034 760,386 2.668%
Biogen Idec Inc 3,087 713,245 2.503%
AbbVie Inc 14,636 685,316 2.405%
Gilead Sciences Inc 11,771 674,977 2.368%
WellPoint Inc 8,472 670,750 2.354%
Boston Scientific Corp 71,748 664,169 2.330%
Amgen Inc 5,932 648,207 2.274%
Life Technologies Corp 8,641 646,596 2.269%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil